Two researchers at the UW Carbone Cancer Center (UWCCC) were named 2010 Young Investigators by the Prostate Cancer Foundation. Joshua Lang and Justine Bruce were awarded three-year grants to continue their research projects on prostate cancer treatments.
Lang, a research fellow, is investigating a prostate cancer vaccine for patients with advanced disease. He will study medications that could attack the body’s immune system to attack tumor cells.
Bruce, assistant professor, Hematology-Oncology, School of Medicine and Public Health, will develop additional imaging techniques and new medicines for patients who do not show evidence of metastatic disease but whose prostate-specific antigen continues to increase after hormonal treatment. She is working with a novel experimental agent that inhibits tumor growth and disease progression.
Lang and Bruce are among a select group of investigators and research fellows from distinguished academic medical centers including Memorial Sloan-Kettering in New York City and the M.D. Anderson Cancer Center and the University of Texas to receive the Young Investigators honor.
The UWCCC is a founding member of the Prostate Cancer Clinical Trials Consortium with the U.S. Department of Defense. The consortium represents the most active prostate cancer clinical research sites in the world.
